JS207 Combination Therapy in Triple-negative Breast Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
JS207 Combination Therapy in Triple-negative Breast Cancer	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma	Recruiting	Phase 2	2026-04-15		NCT07045311

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanghai Junshi Bioscience Co., Ltd.	42

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Hebei University	Baoding	China	2
Affiliated Tumor Hospital of Xinjiang Medical University	Ürümqi	China	1
Anhui Provincial Cancer Hospital	Hefei	China	12
Ceneral Hosipital of Ningxia Medical University	Yinchuan	China	1
Guangdong women and children's hospital and health institute	Guangzhou	China	1
Harbin Medical University Affiliated Cancer Hospital	Harbin	China	1
Henan Cancer Hospital	Zhangzhou	China	1
Hubei Cancer Hospital	Wuhan	China	95
Jiangsu Cancer Hospital	Nanjing	China	19
Jiangsu Province Hospital	Nanjing	China	89
Jilin University First Hospital	Changchun	China	1
Liaoning Cancer Hospital&Institute	Shenyang	China	1
Nanchang People'S Hospital	Nanchang	China	2
Peking University People's Hospital	Beijing	China	146
The Affiliated Hospital of Qingdao University	Qingdao	China	1
The Fifth Medical Center of PLA General Hospital	Beijing	China	4
The First Affiliated Hospital of Xi'an Jiaotong University	Xian	China	2
The First Hospital of China Medical University	Shenyang	China	12
The Second Affiliated Hospital Zhejiang University School of Medicine	Hangzhou	China	11
The Second Hospital of Dalian Medical University	Dalian	China	8
Xi'an International Medical Center Hospital	Xian	China	1

Clinical trials